Intervention

Dendritic cell immunotherapy

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions4

Lead sponsors shown3

Clinical trials

4 shown

Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney DiseaseNCT06866158 · 2024-05-01

ACTIVE_NOT_RECRUITING

MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung CancerNCT04078269 · 2019-08-26

MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung CancerNCT04082182 · 2019-08-26

Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.NCT00043212

Common conditions

Diabetic Kidney Disease (DKD)1 Non-small Cell Lung Cancer1 Non-small Cell Lung Cancer Metastatic1 Prostate Cancer1

Leading sponsors

University Hospital, Ghent2 Northwest Biotherapeutics1 PT. JES Kasih Nusantara Sejahterah1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

UNKNOWN1

WITHDRAWN1

Phase mix

PHASE13

PHASE21

PHASE31

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.